Redsense has submitted application for cross-trading at OTCQX Best Market in the US
OTCQX is a trading platform in the United States operated by the OTC Markets Group for securities not listed on a national stock exchange. The purpose of a cross-trading on OTCQX is to satisfy an increasing interest from US investors and to increase accessibility to the US capital market. Upon possible approval, Redsense Medical shares will be traded with a US ticker symbol and a share price in USD, in US market hours.
"Given that Redsense Medical has most of its revenue in the US, it is also natural that we initiate a process to facilitate for North American investors to trade in the Redsense Medical share. In addition, through a cross-trade on OTCQX, we make it easier for international investors and institutions who are considering having exposure to our shares. This initiative is in line with our increased focus on the US market in general and with a dual-quotation we will meet an increased interest in Redsense Medical”, says Pontus Nobréus, CEO of Redsense Medical AB.
Contact information
For more information, please contact:
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862
ABOUT REDSENSE MEDICAL
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medicalsolves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.